Integrated Whole-Genome Analysis of Hematologic Disorders
Trial ID or NCT#
Status
Purpose
We will use new technologies to look at the DNA, RNA, proteins, and metabolites in the disease-containing blood, bone marrow, or tissue and normal cells from the skin. Our goal is to analyze all of the genes in the diseased and normal skin sample. By comparing the results of the diseased sample and normal skin cells and the results of the two types of genetic information (DNA and RNA), we should be able to identify genetic changes that are important for the initiation, progression, or treatment response of that particular disorder.
Official Title
Integrated Whole-Genome Analysis of Hematologic Disorders Using High-Throughput Sequencing and Array Technologies
Eligibility Criteria
- 1. 18 years of age or older2. Patient meets the clinical and/or pathologic criteria for the hematologic disorder being examined.3. Patient is willing to provide a skin biopsy and five 10 mL tubes of peripheral blood.
- 1. Less than 18 years of age2. Patient is not willing to provide a skin biopsy and five 10 mL tubes of peripheral blood.
Investigator(s)
Contact us to find out if this trial is right for you.
Contact
Jason D Merker
650-922-1885
View on ClinicalTrials.gov